| How the Dynamics of Follow-On Biologics Will Change the Hatch-Waxman Landscape; Master Class: Follow-On Biologics |
ACI Hatch-Waxman Boot Camp |
2010 |
| Patentability of Diagnostics and Gene Sequencing in Light of AMP v. Myriad; Patent Term Extensions and Biosimilars to Optimize Biologic Patent Lifecycle |
ACI Follow On Biologics |
2010 |
| Strategies in Paragraph IV Litigation |
Tianjin Institute of Pharmaceutical Research Seminar |
2009 |
| Strategies in Paragraph IV Litigation and Opportunities in Biosimilars |
Tasly Pharmaceutical 2-Day Seminar |
2009 |
| Stumbling Blocks to Approval of A Regulatory Regime for Follow-On Biologics |
Duke Law: Hot Topics In Intellectual Property |
2009 |
| Basics of Hatch-Waxman Litigation |
API China Conference |
2009 |
| Identifying and Analyzing How the Latest Trends in CAFC Decisions, PTO Rules and Patent Reform Legislation Impact Paragraph IV Motion Practice and Litigation Strategies |
ACI Paragraph IV Disputes NYC |
2008 |